HLA-G and cancer

Seminars in Cancer Biology

Volumn 17, Issue 6, 2007, Pages 411-412

  Carosella, Edgardo D ^a   Horuzsko, Anatolij ^b  

^a Inst Univ d'Hématologie   (France)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ANTIGEN PRESENTING CELL; BREAST CANCER; CANCER GROWTH; CANCER RESEARCH; COLON CANCER; DENDRITIC CELL; DOWN REGULATION; EDITORIAL; GLIOBLASTOMA; HUMAN; IMMUNOSURVEILLANCE; KIDNEY CANCER; LUNG CANCER; MELANOMA; MORBIDITY; NATURAL KILLER CELL; SKIN LYMPHOMA; TUMOR ASSOCIATED LEUKOCYTE;

EID: 35748947217     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2007.06.014     Document Type: Editorial

References (25)

1. Paul P., Rouas-Freiss N., Khalil-Daher I., Moreau P., Riteau B., Le Gal F.A., et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95 (1998) 4510-4515
2. Lefebvre S., Antoine M., Uzan S., McMaster M., Dausset J., Carosella E.D., et al. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol 196 (2002) 266-274
3. Urosevic M., Kurrer M.O., Kamarashev J., Mueller B., Weder W., Burg G., et al. Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 159 (2001) 817-824
4. Fukushima Y., Oshika Y., Nakamura M., Tokunaga T., Hatanaka H., Abe Y., et al. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells. Int J Mol Med 2 (1998) 349-351
5. Wagner S.N., Rebmann V., Willers C.P., Grosse-Wilde H., and Goos M. Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma. Lancet 356 (2000) 220-221
6. Ibrahim E.C., Guerra N., Lacombe M.J., Angevin E., Chouaib S., Carosella E.D., et al. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Cancer Res 61 (2001) 6838-6845
7. Urosevic M., Willers J., Mueller B., Kempf W., Burg G., and Dummer R. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 99 (2002) 609-617
8. Rouas-Freiss N., Moreau P., Menier C., and Carosella E.D. HLA-G in cancer: a way to turn off the immune system. Semin Cancer Biol 13 (2003) 325-336
9. Moreau P., Mouillot G., Rousseau P., Marcou C., Dausset J., and Carosella E.D. HLA-G gene repression is reversed by demethylation. Proc Natl Acad Sci USA 100 (2003) 1191-1196
10. Dunn G.P., Old L.J., and Schreiber R.D. The three Es of cancer immunoediting. Annu Rev Immunol 22 (2004) 329-360
11. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186 (1997) 1809-1818
12. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7 (1997) 273-282
13. Brown D., Trowsdale J., and Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64 (2004) 215-225
14. Ristich V., Liang S., Zhang W., Wu J., and Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 35 (2005) 1133-1142
15. LeMaoult J., Zafaranloo K., Le Danff C., and Carosella E.D. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 19 (2005) 662-664
16. Liang S., Zhang W., and Horuzsko A. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function. Eur J Immunol 36 (2006) 2457-2471
17. Pazmany L., Mandelboim O., Vales-Gomez M., Davis D.M., Reyburn H.T., and Strominger J.L. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274 (1996) 792-795
18. Munz C., Holmes N., King A., Loke Y.W., Colonna M., Schild H., et al. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med 185 (1997) 385-391
19. Mandelboim O., Pazmany L., Davis D.M., Vales-Gomez M., Reyburn H.T., Rybalov B., et al. Multiple receptors for HLA-G on human natural killer cells. Proc Natl Acad Sci USA 94 (1997) 14666-14670
20. Rajagopalan S., and Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189 (1999) 1093-1100
21. van den Elsen P.J., Holling T.M., Kuipers H.F., and van der Stoep N. Transcriptional regulation of antigen presentation. Curr Opin Immunol 16 (2004) 67-75
22. Chang C.C., Campoli M., and Ferrone S. HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?. Curr Opin Immunol 16 (2004) 644-650
23. Rouas-Freiss N., Moreau P., Ferrone S., and Carosella E.D. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?. Cancer Res 65 (2005) 10139-10144
24. Fournel S., Aguerre-Girr M., Huc X., Lenfant F., Alam A., Toubert A., et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 164 (2000) 6100-6104
25. Le Rond S., Azema C., Krawice-Radanne I., Durrbach A., Guettier C., Carosella E.D., et al. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J Immunol 176 (2006) 3266-3276